LITMUS Imaging Study (NCT05479721)
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & Validation of Imaging Modality Performance Across the NAFLD Spectrum in a Prospectively Recruited Cohort
🩺 Plain-English Summary (8th-Grade Level)
The LITMUS Imaging Study is a prospectively recruited, observational study of patients with histologically characterised non-alcoholic fatty liver disease (NAFLD). It aims to evaluate the diagnostic performance of imaging biomarkers (ultrasound elastography and magnetic resonance biomarkers) against NAFLD histological scores in a cross-sectional analysis and the natural history of NAFLD in a longitudinal study.
Who can join: Review the eligibility criteria below.
Location: Pinnacle Clinical Research — San Antonio, Texas
Age range: 18 Years to 100 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Pinnacle Clinical Research — San Antonio, Texas
- Helsinki University Hospital — Helsinki,
- Le Centre de Recherche Clinique (CRC) du CHU d'Angers — Angers,
- Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière — Paris,
- UNIVERSITÄTSMEDIZIN der Johannes Gutenberg Universität Mainz — Mainz,
- Universitätsklinikums Würzburg — Würzburg,
- Laiko General Hospital of Athens — Athens,
- Università di Palermo — Palermo,
- Department of Medical Sciences University of Torino — Torino,
- Vall d'Hebron University Hospital — Barcelona,
- Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocío University Hospital — Seville,
- HU Clínico de Valladolid — Valladolid,
- Linköping University Hospital — Linköping,
- Inselspital, University Hospital — Bern,
- Addenbrookes Hospital — Cambridge,
- The Newcastle Upon Tyne Hospitals Nhs Foundation Trust — Newcastle upon Tyne,
- Queens Medical Centre — Nottingham,
- Oxford University Hospitals NHS Foundation Trust — Oxford,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in NAFLD
- Accurate Point of Care Liver Disease Diagnostics — La Jolla, California
- Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD — Iowa City, Iowa
- Nonalcoholic Fatty Liver Disease in HIV Database — Birmingham, Alabama
- An Imaging-based Quantitative Biomarker Assay for NAFLD in Children — Madison, Wisconsin
- Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV — Tuscaloosa, Alabama
Explore by condition: All NAFLD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.